Previous Article | Next Article 
Infect Immun, June 1998, p. 2486-2493, Vol. 66, No. 6
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Activity of Protegrins against Yeast-Phase
Candida albicans
Yoon
Cho,1
Jeffrey S.
Turner,1
Nhu-Nguyen
Dinh,1 and
Robert
I.
Lehrer1,2,*
Department of
Medicine1 and
Molecular Biology
Institute,2 UCLA School of Medicine, Los
Angeles, California
Received 17 December 1997/Returned for modification 29 January
1998/Accepted 5 March 1998
 |
ABSTRACT |
We used a two-stage radial diffusion assay to perform a
structure-activity study of the antifungal effects of protegrin-1 (PG-1) on yeast-phase Candida albicans. While doing so, we
computed MICs from the radial diffusion assay data by three
methods and compared the respective values with results from colony
count and broth microdilution assays. This allowed us to identify
several technical modifications that improved the sensitivity and
accuracy of radial diffusion assays. We found that both PG-1 and
enantiomeric PG-1 (composed exclusively of D-amino acids)
were potently fungicidal for yeast-phase C. albicans. The
protegrins PG-2, -3, and -5, but not PG-4, were as effective as PG-1.
At least one intramolecular disulfide bond was required to retain
optimal candidacidal activity at physiological NaCl
concentrations. Truncated variants of PG-1 that lacked its first four
residues showed decreased candidacidal activity, although their
activity against bacteria was substantially intact. Altering the
-turn region (residues 9 to 12) of PG-1 or its variants further
decreased candidacidal activity. These studies suggest that only 12 residues are needed to endow protegrin molecules with strong
antibacterial activity and that at least 4 additional residues are
needed to add potent antifungal properties. Thus, the 16-residue
protegrin PG-2 likely represents the minimal structure needed for
broad-spectrum antimicrobial activity encompassing bacteria and fungi.
 |
INTRODUCTION |
Protegrins, small
-sheet
antimicrobial peptides found in porcine leukocytes (1, 4,
12), are members of the cathelicidin family (36, 38),
a large group of structurally diverse antimicrobial peptides whose
precursors contain a highly conserved cathelin domain (34).
Because protegrins exert broad-spectrum antibacterial activity
(12), show efficacy in experimental murine infections (24), and are readily prepared by solid-phase synthesis,
they make attractive templates for analyzing the properties of
-sheet peptide antibiotics (8, 16, 20, 33). In addition
to their antibacterial properties, protegrins can inactivate
certain enveloped viruses (31) and show in vitro activity
against Candida albicans (12). Unlike defensins,
the larger
-sheet peptides found in the leukocytes and
epithelial cells of humans and other animals (17),
protegrins retain antimicrobial activity in the presence of
extracellular NaCl concentrations (8).
The solution structure of protegrin-1 (PG-1) was established by
two-dimensional nuclear magnetic resonance spectroscopy (1, 4) and is shown schematically in Fig.
1. Its principal structural features
include the antiparallel
-sheets formed by residues 5 to 8 and 13 to
16 and the four-residue turn made by residues 9 to 12. Except for a
tyrosine residue, the
-sheet region contains apolar residues, while
the positively charged arginines are present at both ends and clustered
in the turn. The overall structure is strongly amphipathic.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 1.
Structure of PG-1. The two intramolecular disulfide
bonds are represented by thick black bars. The asterisk denotes
C-terminal amidation. Several residues are numbered.
|
|
We performed this study to examine how the various regions of a
protegrin molecule contributed to in vitro activity against C. albicans. We made and tested more than 20 variants of PG-1. These
included an enantiomeric PG-1 composed exclusively of
D-amino acids, three alanine-substituted analogs that
lacked one or both disulfide bonds, and various truncated forms with 10 to 16 residues and two disulfides.
 |
MATERIALS AND METHODS |
Peptides.
Rabbit
-defensin NP-2 was isolated from
peritoneal exudate granulocytes (22). The protegrin PG-4 was
a generous gift from IntraBiotics Pharmaceuticals, Inc. (Sunnyvale,
Calif.). The other protegrin-related peptides used in this study were
custom synthesized, either by SynPep Corporation (Dublin, Calif.) or by
the University of Arizona Macromolecular Structure Facility (Tucson,
Ariz.), and then purified in our laboratory. Table
1 shows the primary structures, masses,
and numbers of residues of the protegrin peptides described in this
report.
Purification and folding.
Crude synthetic peptides were
dissolved at 10 mg/ml at 52°C in an anaerobic reducing buffer (pH
8.07) that contained 6 M guanidine chloride, 0.02 M EDTA, 0.5 M Tris,
and dithiothreitol (DTT) such that the molar ratio of DTT to peptide
was 14:1. After 2.5 h, 50% more DTT was added to ensure complete
reduction, and 45 min later, glacial acetic acid (5% final
concentration) was added to stabilize the products. The reduced
peptides were purified by reverse-phase high-pressure liquid
chromatography and dissolved at 0.1 mg of peptide/ml in 0.1 M Tris
buffer (pH 7.68). Intramolecular disulfide bonds were formed by
stirring the peptides for 24 to 52 h at ambient temperature in
room air. The "bullet" and "kite" forms of PG-1 (Table 1) were
oxidized in a buffer that contained 10% (vol/vol) dimethyl sulfoxide
to enhance disulfide bond formation (30).
Purification procedures were monitored by acid-urea polyacrylamide gel
electrophoresis. Folding was confirmed by fast atom
bombardment mass
spectrometry, which showed a loss of 4 mass units
after successful
folding of protegrins that contained two disulfide
bonds. For example,
the calculated masses of reduced and oxidized
PC-79 are 1,519.9 and
1,515.9 mass units, respectively. We found
their measured masses to be
1,520.2 and 1,516.7 mass units, respectively.
Protegrin concentrations
were determined by spectrophotometry
at 280 nm, using the formulae of
Pace et al. (
18). According
to these, the theoretical molar
extinction coefficients (

) of
PG-1 and PG-4 are 1,740 and 7,240, respectively. The actual molar
extinction coefficient of PG-1 was
within 8% of the theoretical
value when we determined it by
quantitative amino acid analysis
(data not shown).
Fungi.
C. albicans UC820 is a clinical isolate that
has been laboratory passaged for almost 30 years (13). Two
recent clinical isolates of C. albicans, taken from vaginal
and blood cultures, were provided by Elizabeth A. Wagar of the UCLA
Clinical Microbiology Laboratory. Four American Type Culture Collection
strains of C. albicans, ATCC 32354 (serotype A), ATCC 36802 (serotype B), ATCC 24433 (used to assay amphotericin B), and ATCC
14053, were purchased from the American Type Culture Collection
(Rockville, Md.). Archival laboratory stocks of these strains were
prepared by growing the cultures overnight at 37°C in Sabouraud
dextrose broth (Difco, Detroit, Mich.) and transferring 0.5-ml volumes
into 0.5 ml of 20% glycerol for frozen storage at
80°C.
Growth conditions.
Master plates were prepared every 3 weeks
by streaking our archival laboratory stocks onto Sabouraud dextrose
agar plates (Clinical Standard Laboratories, Rancho Dominguez, Calif.)
and incubating them overnight at 37°C. The yeast-phase C. albicans used in experiments was obtained by picking a single
colony, placing it into 50 ml of Sabouraud dextrose broth, and
incubating the subculture in a shaking water bath at 37°C for 16 to
20 h.
Two-stage radial diffusion assay.
The rationale and
methodology for the two-stage radial diffusion assay have been
described elsewhere in detail (15, 25). Briefly, washed
yeast-phase C. albicans cells were counted in a
hemocytometer. Ten milliliters of molten (43°C) underlay gel solution
was mixed with 4 × 106 CFU and poured into a 9- by
9-cm petri dish (Nunc, Naperville, Ill.), where it formed a
1.23-mm-high gel. Low-ionic-strength underlay gels contained 1%
agarose (Sigma A-6013), 0.3 mg of Sabouraud dextrose broth powder
(Difco 0382-17-9) per ml, and 10 mM sodium phosphate buffer, pH 7.4. High-ionic-strength underlay gels also contained 100 mM NaCl but were
otherwise identical in composition. A regular array of 3.2-mm-diameter
wells was punched into the underlay gel. Their potential capacity (9.9 µl) easily accommodated the introduction of 5-µl peptide samples
that had been serially diluted in sterile acidified water (0.01%
acetic acid), using 1.5-ml conical polypropylene microcentrifuge tubes
(United Scientific Products, San Leandro, Calif.).
After the peptides had been added, the plates were inverted and
incubated for 3 h at 37°C, during which time the peptides
diffused into the underlay gel from the wells. A 43°C molten overlay
gel (10 ml of 1% agarose, 60 mg of Sabouraud dextrose broth powder
per
ml, and 10 mM sodium phosphate buffer, pH 7.4) was poured,
and the
plates were incubated overnight at 37°C. The diameters
of the clear
zones surrounding the wells were measured to the
nearest 0.1 mm with
a ×7 magnifier. The zone boundaries were sharp.
Core samples
removed from the clear area and triturated in buffer
yielded no
colonies when spread over Sabouraud agar plates and
cultured for
48 h.
The MIC was calculated by three methods. One involved performing a
linear least-mean-squares fit to the data relating log
10 peptide concentration (in micromolar or micrograms per milliliter)
to
zone size in units, as previously described (
25). This value
is called the MICa in this report. The second involved performing
a
least-mean-squares fit for data relating log
10 peptide
concentration
to the zone diameter or area in square millimeters. A
rationale
for this calculation has been described previously
(
3), and
the resulting value, called the MICb in this
report, has also
been called the critical concentration (
3).
Finally, we used
the equations proposed by Hultmark and associates
(
9,
10)
to calculate the lethal concentration (their
terminology).
Studies with bacteria.
PG-1 and PC-17, a truncated variant
of PG-1 that lacked residues 1, 2, 3, 4, 17, and 18, were also tested
against several gram-positive and gram-negative bacteria in radial
diffusion assays. These underlay gels contained 10 mM sodium phosphate
buffer (pH 7.4) and 0.3 mg of Trypticase soy broth powder per ml, with
or without 100 mM NaCl, and the overlay gel was double-strength
(60-g/liter) Trypticase soy broth powder with 1% agarose. The peptides
were serially diluted in 0.01% acetic acid with 0.1% human serum
albumin (Sigma A-8763). Mid-logarithmic-phase bacteria were prepared as previously described and added to the underlay at a final concentration of 2 × 105 to 4 × 105 CFU/ml. MICa
values were calculated as summarized above and elsewhere (25).
Colony count assays.
C. albicans, grown as for the
radial diffusion assays, was washed twice in 10 mM sodium phosphate
buffer (pH 7.4) and counted in a hemocytometer. Various final
concentrations, from 2 × 103 to 2 × 106 CFU/ml, were exposed to a range of PG-1 concentrations
in 200 µl of 10 mM sodium phosphate buffer (pH 7.4) containing 0.3 mg of Sabouraud dextrose broth powder per ml with or without 100 mM sodium
chloride. At selected times, aliquots were removed and either plated
directly on Sabouraud agar plates or diluted appropriately with 10 mM
phosphate buffer and then transferred to the plates with a
SpiralSpreader (SpiralTech, Rockville, Md.). Colonies were counted
after incubation for 24 to 48 h at 37°C.
Broth microdilution assays.
The procedures described below
correspond to the proposed standard reference method for broth dilution
antifungal susceptibility testing (17a), performed in a
"micro" format. Briefly, C. albicans UC820 was grown
overnight in Sabouraud dextrose broth, washed in RPMI 1640 medium
(Gibco BRL) containing 0.165 M 3-(N-morpholino) propanesulfonic acid (MOPS) buffer (pH 7.0), counted in a
hemocytometer, and adjusted to 2.0 × 103/ml in
RPMI-MOPS. The peptides were serially diluted in 0.01% acetic acid
with 0.1% human serum albumin (Sigma A-8763). Two overlapping sets of
serial twofold peptide dilutions were tested in each experiment. One
series ranged from 37.0 to 1.16 µg/ml (final concentrations, after
dilution), and the other ranged from 27.75 to 0.87 µg/ml. One hundred
microliters of yeast suspension and 11 µl of 10×-concentrated
peptide were mixed together and incubated for 46 to 50 h at 37°C
in polypropylene 96-well plates (Costar 3790). After the plates were
examined to determine the MICs, the entire content (111 µl) of all
wells without evident growth was plated on Sabouraud agar plates and
incubated for 24 to 48 h to determine the minimal fungicidal
concentrations (MFCs).
 |
RESULTS |
Radial diffusion assays.
Table 2
shows the MICa, MICb, and lethal concentration values obtained for
porcine protegrins PG-1 to -5. The results of radial diffusion assays
for four of these protegrins (PG-1, -2, -3, and -5) are also shown
graphically in Fig. 2, to illustrate the
linearity of the assays used to obtain the data summarized in Table 2.
In the left panel of Fig. 2, the MICa corresponds to the x
intercept. In the right panel, the MICb corresponds to the
x-axis coordinate of the point where the line representing zone area intersects the horizontal line whose y coordinate
denotes the area (8.04 mm2) of the 3.2-mm-diameter sample
wells.

View larger version (22K):
[in this window]
[in a new window]
|
FIG. 2.
Two-stage radial diffusion assays. PG-1, -2, -3, and -5 were tested against C. albicans. The sample size was 5 µl,
and no albumin was used in the diluent. Each symbol represents a mean
value from three replicate experiments, except that for PG-1
(n = 7). Error bars show SEMs. The regression lines
(least-mean-squares fits) are as follows: for PG-1 data, thick and
solid, for PG-2 data, dotted; for PG-3 data, dashed; for PG-5 data,
thin and solid. The left panel illustrates data that would be analyzed
in a MICa calculation. The right panel shows the same data as they
would be expressed to determine the MICb.
|
|
Whereas PG-1, -2, -3, and -5 had similar MICa and MICb values, PG-4 was
only about half as potent. Since the primary structures
of PG-1 and
PG-4 differ only in their turn residues, which are
RRRF in PG-1 and
RGWI in PG-4, the reduced potency of PG-4 was
our first indication that
the turn structure influenced activity
against
C. albicans.
The turn residues will be revisited below.
Table
2 also shows that enantiomeric PG-1, composed exclusively of
D-amino acids, was at least as active as normal PG-1.
Overall, the MICa values for PG-1 to -5 were 80.3 ± 3.9% of the
corresponding MICb values (range, 71 to 98%). The lethal
concentrations
were considerably lower, only 18.4 ± 0.9 and
14.8 ± 1.1% of the
corresponding MICa and MICb.
Broth microdilution assays.
We examined the activity of PG-1
against C. albicans UC820 in three broth microdilution
assays, each performed on a different day. The assay results were
identical. The MICs and MFCs for PG-1 were identical, with each being
between 0.77 and 1.08 µM. The MICs and MFCs for PG-4 were about
threefold higher, between 2.26 and 3.39 µM, confirming our findings
in the radial diffusion assays (Table 2).
Colony count assays.
We were initially disconcerted to find
that the MICa values obtained from our radial diffusion assays were
more than double the MIC and MFC values obtained from broth dilution
assays, and we turned to colony count experiments to see which values
were correct. We found that when the broth microdilution assays and colony count experiments were performed in the same medium, their results corresponded perfectly (Fig. 3).
Consequently, we reexamined our radial diffusion assay procedure to
identify factors that caused it to underestimate potency.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 3.
Comparison of colony count and broth microdilution
assays. The broth microdilution assays were performed with 2 × 103 CFU/ml in an RPMI 1640-based medium. The colony count
assays used two different C. albicans concentrations
(104 and 105 CFU/ml) and were performed in the
high-salt medium (without agarose) that was used in radial diffusion
assays. Three different incubation times (5, 60, and 180 min) were used
in the colony count assays.
|
|
We identified two technical factors whose effects were largely
responsible for this. They proved to be a matter of simple
geometry.
Although the height of the underlay gel (1.23 mm) and
the diameter of
the well (3.2 mm) gave the wells a capacity of
9.89 µl, we had added
only 5 µl of sample. Consequently, when
the peptide solutions entered
the underlay gel, the peptides not
only diffused outward (radially) but
also diffused upward to occupy
the full height of the underlay gel. In
effect, the upward diffusion
effectively diluted the peptide
concentration placed into the
well by about half (5/9.89 = 50.5%). To confirm the consequences
of this effect, we compared MICa
values obtained after applying
5- and 8-µl samples from the same
dilution series to seven replicate
plates. Samples larger than 8 µl
were difficult to instill without
causing occasional overflows. Tests
performed with the 5-µl samples
yielded a MICa of 3.23 ± 0.199 µM (mean ± standard deviation),
whereas those performed
with 8-µl samples yielded a MICa of 2.02
± 0.084 µM. The
ratio of these mean values (2.02

3.23 = 0.67)
was
remarkably close to the theoretical value (0.625) expected
from the
ratio (5 µl/8 µl) of the sample volumes.
The other technical factor was, in retrospect, even more obvious. By
preparing serial peptide dilutions in the absence of
a carrier protein,
amphipathic peptide was lost from solution
via nonspecific adsorption
to the plastic tubes. This effect disproportionately
affected the
lowest concentrations of peptides in a dilution series
and could
largely be prevented by adding 0.1% albumin to the diluting
solution
to block the tubes. When we performed the radial diffusion
assays with
8-µl samples and used peptides diluted in 0.01% acetic
acid with
0.1% albumin, the resulting MICa of 1.07 ± 0.075 µM
(mean ± standard error of the mean [SEM]) was completely consistent
with
the broth microdilution and colony count assays. These experimental
results are shown in Fig.
4. When these
same data were calculated
by the other formulae described in Materials
and Methods, the
MICb was 1.11 ± 0.136 µM and the lethal
concentration was 0.505
± 0.014 µM (means ± SEMs).
Because these technical epiphanies
occurred after most of the radial
diffusion data had already been
collected, the marginal benefits of
redoing the experiments did
not justify the cost and effort that this
would entail.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 4.
Effects of sample volume and an albumin carrier.
Seven replicate radial diffusion experiments were done, using either 5- or 8-µl samples that had been serially diluted in the presence or
absence of 0.1% human serum albumin (HSA). Note the effects of these
changes on the MIC, which corresponds to the x intercept.
The regression lines for the data points (least-mean-squares fit) are
as follows: solid line, 5 µl without HSA; dashed line, 8 µl without
HSA; dotted line, 8 µl with HSA.
|
|
Kinetics.
In other colony count studies, we examined the
effect of the medium on the kinetics of candidacidal activity. At a
given concentration of PG-1, killing occurred more rapidly in a
low-salt medium (10 mM buffer) than when the medium contained buffer
plus 100 mM NaCl. For example, whereas addition of 4.35 µM PG-1 to
1.48 × 106 C. albicans CFU/ml reduced the
colony count in 5 min by >4 log10 units in low-salt
medium, it achieved only a 1.9-log10-unit reduction in 5 min in the high-salt medium. By 30 min, the same
>4-log10-unit decrease was also achieved in the medium
comprised of buffer plus 100 mM NaCl. Candidacidal activity occurred
even more slowly in the RPMI-MOPS medium. For example, when the
inoculum (2 × 103 CFU/ml) was exposed to 2.1 µM
PG-1 in RPMI-MOPS, 25% of the yeast cells remained viable after 60 min, as determined by quantitative subculture, and 1% were still
viable after 120 min. No survivors were found at 3, 4, 5, or 6 h.
When 2.1 µM PG-1 was added to the same concentration of C. albicans in our customary underlay medium (buffer plus 100 mM
NaCl), no fungi survived after a 1-h exposure. When we tested higher
concentrations (>106 CFU/ml) of C. albicans in
the 100 mM NaCl medium, 2.45 to 4.5 µM PG-1 sterilized the inoculum
by 30 min, and 8.9 µM PG-1 caused a 4-log10-unit kill
within 5 min.
Other Candida strains.
Although we used C. albicans UC820 in most of our studies, we also tested PG-1 against
six other C. albicans strains, including two that were
fresh clinical isolates (Table 3). Since
all seven strains showed equal susceptibility to PG-1, we concluded
that UC820 was representative of the species.
Effect of added cations.
Although most of the data presented
in this paper were obtained from assays performed at physiologic NaCl
concentrations (100 mM), we also tested the peptides in low-salt
underlays. Table 3 also shows that whereas 100 mM NaCl did not affect
the candidacidal activity of PG-1, rabbit
-defensin NP-2 lost its
effectiveness (MICb > 65 µM) even though it was slightly more
potent than PG-1 on a molar basis (MICb = 1.75 ± 0.07 µM)
when tested in low-salt (buffer-only) underlays. As we had previously
noted that divalent cations adversely affect the candidacidal activity
of defensins in low-salt media (14), we tested the effects
of Ca2+ and Mg2+ on protegrins. Addition of
either 1 mM Ca2+ or 1 mM Mg2+ to low- or
high-salt underlays had very little effect on anticandidal activity
(Fig. 5), but in combination, these
divalent cations did reduce the efficacy of PG-1, especially in 100 mM
NaCl.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 5.
Effects of divalent cations on activity against C. albicans. The bars show MICa values (means ± SEMs) from
three experiments that were performed with underlay gels containing 10 mM phosphate buffer with or without 100 mM NaCl. The gels were
supplemented with 1 mM Ca2+ and/or 1 mM Mg2+ as
shown.
|
|
Disulfide structure.
Native protegrins, like PG-1, contain two
intramolecular disulfide bonds that pair Cys6:Cys15 and Cys8:Cys13
(Fig. 1). To learn if these disulfides contributed to activity against
C. albicans, we made alanine-substituted protegrins that
lacked one or both cysteine pairs. The disulfide-free
("snake") protegrin variant lacked candidacidal activity in
100 mM NaCl. In contrast, the "bullet" protegrin variant, which
contained only the Cys6:Cys15 disulfide bond, retained about 70% of
the potency of PG-1, and the "kite" variant, with only a Cys8:Cys13
disulfide bond, retained about 50% (Table
4). All three disulfide variants showed
excellent activity against C. albicans when their activities
were tested in low-salt underlays. The MICa values (mean ± SEM,
n = 3) for the respective peptides were as follows:
snake, 1.03 ± 0.27 µM; kite, 0.93 ± 0.16 µM; and
bullet, 0.89 ± 0.02 µM.
Optimal length.
Native protegrins contain 18 amino acid
residues, except for PG-2, which has 16 (Table 1). Except for its
Val14
Ile14 substitution and its deletion of residues 17 and 18 (Gly-Arg), PG-2 is identical to PG-1. To determine how truncations of
PG-1 affected its activity against C. albicans, we prepared
a series of deletion mutants (Tables 1 and
5). Removal of two C-terminal residues
(PC-13) was well tolerated, but elimination of three C-terminal
residues (PC-45) reduced potency by 70%. The N-terminal residues were
clearly even more important, since deletion of residues 1 to 4 (PC-11) or residues 1 to 5 (PC-37) reduced the potency against C. albicans by 73 and 90%, respectively. When we deleted four
N-terminal and two C-terminal residues (PC-17), potency was decreased
by 76% relative to that of PG-1. The indifferent performance of PC-17 against C. albicans stands in marked contrast to its strong
antibacterial effects (Table 6).
When we deleted five N-terminal and three C-terminal residues from
PG-1, the potency of the resulting decapeptide peptide
(PC-73) was
reduced by >98% relative to that of PG-1. From these
data, we
concluded that each region of the PG molecule, with the
exception of
residues 17 and 18, contributed substantially to
activity against
C. albicans. In contrast, only 12 residues (residues
5 to
16) and their two associated disulfide bonds (Fig.
1) sufficed
to endow
PG-1 with strong antibacterial properties (Table
6).
Nature and placement of turn residues.
As shown in Table 1,
the turn regions (residues 9 to 12) of PG-1, -2, and -3 are identical
(RRRF). They differ slightly from that in PG-5 (RPRF) but markedly from
that in PG-4 (RGWI). To explore the consensus RRRF turn motif, we
constructed and successfully refolded six variants that were based on
the structure of PC-17, a truncated form of PG-1 (Table 1). In three
variants (PC-78, -79, and -80), we maintained the turn's composition
(three arginines and one phenylalanine) but varied the placement of the
residues. All three variants were substantially less effective than
PC-17 (Table 7). PC-77, with four
arginine residues in its turn, showed about half the potency of PC-17,
and PC-81, which had an RRFF turn, was completely inactive. Additional
members of this series containing only arginine and phenylalanine
residues in the turn region were synthesized but could not be folded.
Taken together with the reduced candidacidal activity shown by PG-4
(Table 2), these results indicate that the turn region residues play an
important part in activity against C. albicans.
Retention of susceptibility to PG-1.
We performed the
following experiment to determine if repeated exposures to PG-1 induced
or selected resistant C. albicans. The organisms (suspended
in 10 mM phosphate buffer plus 100 mM NaCl plus 1% [vol/vol]
Sabouraud broth) were exposed for 3 h at 37°C to PG-1 (1.45, 2.9, 5.8, or 11.6 µM). The initial experiment was performed with
0.7 × 106 CFU/ml. Only 102 CFU/ml
survived exposure to 1.45 µM PG-1, and none survived higher concentrations. Four surviving colonies (named clones A, B, C, and D)
were picked individually and grown overnight. We exposed approximately
1.5 × 106 CFU/ml derived from clones A to D to 1.45 to 11.6 µM PG-1 for 3 h as described above. Over 99% were
killed by 2.9 µM PG-1, and all were killed by the higher PG-1
concentrations. In the third experiment, 50 colonies that had survived
exposure to 2.9 µM PG-1 were picked from each of the four clones (A
to D), pooled, and used to inoculate four fresh overnight cultures.
After exposure to PG-1, over 99% of the progeny of each clone were
killed by 2.9 µM, and all organisms were killed by 5.8 µM. In the
fourth and final experiment, 50 colonies were derived from each clone that had survived their third exposure to 2.9 µM PG-1. These were pooled and used to inoculate four fresh overnight cultures. Once again,
over 99% of each clone's progeny were killed by 2.9 µM PG-1, and
all organisms were killed by 5.8 µM. Thus, at least under these
experimental conditions, repeated exposure to PG-1 did not appear to
induce or select for resistant mutants.
 |
DISCUSSION |
The prominence of methodology in this report requires a few
brief comments to open the discussion. We have relied upon two-stage radial diffusion assays in our natural-product research because they
are quantitative and sensitive and consume minimal quantities of the
molecules being studied. Our usual practice has been to use 5-µl
samples and to calculate x intercepts from plots that relate
log10 peptide concentrations to the resulting zone
diameters. This practice yielded the MICa calculations shown in this
report. Although the use of 5-µl samples was peptide sparing and
produced internally consistent data, it yielded values that were about twice as high as those obtained from conventional broth microdilution assays, for reasons discussed in Results. Simply by filling up the
sample wells closer to their capacity, i.e., by using 8-µl samples
instead of 5-µl samples, the MICa values agreed much more closely to
those from broth microdilution assays. The other improvements involved
steps to decrease peptide loss via nonspecific adsorption: using
polypropylene tubes and plates and adding 0.1% albumin to the
acidified water diluent.
Several alternative methods, in addition to the one we described
(15, 25), have been used to calculate MICs from radial diffusion data. One of these calculates the MIC from the relationship between the zone area and the log10 peptide concentration.
This value has been named the critical concentration by others
(3) and was called the MICb in this report. When we
calculated it from our data, the resulting values were very close to
the MICa. The lethal concentration formulae (9, 10) were
developed by Hultmark and associates from theoretical considerations,
and their application to our data yielded MICs that were about twofold lower than MICa or MICb values obtained under optimal experimental conditions (i.e., with 8-µl samples, 0.01% albumin diluent, and polypropylene containers). These lethal concentrations were also below
the MICs that we obtained from colony counting and broth microdilution
assays (Fig. 3). Overall, the three calculation methods (MICa, MICb,
and lethal concentration) agreed reasonably well with each other and
with the widely used broth microdilution assay. When the radial
diffusion assays were performed with 5-µl samples and without an
albumin-containing diluent, the lethal-concentration calculation tended
to overestimate protegrin potency, whereas the MICa calculation
underestimated it.
Mounting evidence indicates that antimicrobial peptides play key roles
in the innate immune defenses of vertebrates, invertebrates, and
plants. Protegrins and the structurally analogous tachyplesins (11), found in horseshoe crabs, are distinctive among
-sheet peptides because of their structural simplicity, their
unusually potent and broad-spectrum antimicrobial properties, and their retention of activity in normal or elevated concentrations of NaCl.
Although porcine leukocytes lack defensins, they contain a multitude of
cathelicidins, including up to five protegrins, plus at least two
-helical (27, 32), and three proline-rich (6, 7, 28,
37) peptides. Porcine neutrophil proprotegrins lack microbicidal
activity (19) until the cathelin and protegrin domains are
separated by limited proteolysis. Whereas the larger and structurally
more complex
-sheet defensins of human leukocytes are sequestered in
cytoplasmic granules whose contents are delivered preferentially to
intracellular phagosomes, cathelicidins are typically found in
secretory granules of neutrophils and are readily released to the
plasma (6).
Although many endogenous antimicrobial peptides are known,
relatively few of them manifest antifungal properties, especially in
the presence of physiological extracellular concentrations of sodium
chloride (data not shown). The findings of this study underlined the
importance of the intramolecular disulfide bonds that stabilize the
-sheet structure of protegrins for activity against yeast-phase
C. albicans. When both disulfide bonds were eliminated by
substituting alanines for all four regularly conserved cysteines, the
resulting linearized (snake) peptide lost its activity to kill C. albicans. While the retention of both intramolecular disulfide
bonds was optimal, the kite and bullet variants of PG-1 retained 50 to
70% of the activity of the parent molecule, even though each contained
only one disulfide bond. As we previously obtained similar results in
studies with gram-positive and gram-negative bacteria and with model
membranes (8), it is clear that retention of the
-sheet
structure is important for antifungal activity in the extracellular
environment.
Several natural antimicrobial peptides with single intramolecular
disulfide bonds have been described, including two dodecapeptides found
in bovine (21) and ovine (2, 26) leukocytes. Both of these peptides are produced on cathelin-containing precursors, and their sequences are quite similar: RLCRIVVIRVCR (bovine) and RICRIIFLRVCR (ovine). The uni-disulfide kite and bullet
protegrins also show some resemblance to other naturally occurring
peptides, including thanatin (GSKKPVPIIY CNRRTGKCQR M) and brevinin-1
(FLPVLAGIAA KVVPALFCKI TKKC). Thanatin is a 21-residue peptide that
appears in the hemolymph of the insect Podisus maculiventris
after immune challenge (5), and brevinin-1 is one of many
such peptides found in the skin of frogs (23, 29). In both
of these peptides, a C-terminally located disulfide bridge delineates a
cationic loop that, along with its flanking residues, is important for antimicrobial activity. Both thanatin and brevinin-1 have bactericidal and fungicidal properties.
While it should prove possible to modify the structure of protegrins to
alter their pharmacokinetic properties or to improve their
biocompatibility, the present results suggest that the native protegrin
design is already a remarkably economical one. Indeed, the 16-residue
protegrin PG-2 may already approach the minimal structure that is
capable of exerting strong activity against gram-positive bacteria,
gram-negative bacteria, and fungi in an extracellular environment.
 |
ACKNOWLEDGMENTS |
The late Sylvia Harwig contributed substantially to the design
and purification of the protegrin variants. We thank Debbie Steinberg
of IntraBiotics for suggesting the use of albumin in radial diffusion
assays.
This work was supported by Public Health Service grants AI 37945 and AI
22839.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Medicine, Box 951690, 10833 LeConte Ave., Los Angeles, CA 90095-1690. Phone: (310) 825-5340. Fax: (310) 206-8766. E-mail:
rlehrer{at}med1.medsch.ucla.edu.
Editor: T. R. Kozel
 |
REFERENCES |
| 1.
|
Aumelas, A.,
M. Mangoni,
C. Roumestand,
L. Chiche,
E. Despaux,
G. Grassy,
B. Calas, and A. Chavanieu.
1996.
Synthesis and solution structure of the antimicrobial peptide protegrin-1.
Eur. J. Biochem.
237:575-583[Medline].
|
| 2.
|
Bagella, L.,
M. Scocchi, and M. Zanetti.
1995.
cDNA sequences of three sheep myeloid cathelicidins.
FEBS Lett.
376:225-228[Medline].
|
| 3.
|
Barry, A. L.
1980.
Procedures for testing antibiotics in agar media: theoretical considerations, p. 1-23.
In
V. Lorian (ed.), Antibiotics in laboratory medicine. Williams and Wilkins, Baltimore, Md.
|
| 4.
|
Fahrner, R. L.,
T. Dieckmann,
S. S. L. Harwig,
R. I. Lehrer, and J. Feigon.
1996.
Solution structure of protegrin 1, a broad spectrum antimicrobial peptide from procine leukocytes.
Chem. Biol.
3:543-550.
[Medline] |
| 5.
|
Fehlbaum, P.,
P. Bulet,
S. Chernysh,
J. P. Briand,
J. P. Roussel,
L. Letellier,
C. Hetru, and J. A. Hoffmann.
1996.
Structure-activity analysis of thanatin, a 21-residue inducible insect defense peptide with sequence homology to frog skin antimicrobial peptides.
Proc. Natl. Acad. Sci. USA
93:1221-1225[Abstract/Free Full Text].
|
| 6.
|
Gudmundsson, G. H.,
K. P. Magnusson,
B. P. Chowdhary,
M. Johansson,
L. Andersson, and H. G. Boman.
1995.
Structure of the gene for porcine peptide antibiotic PR-39, a cathelin gene family member: comparative mapping of the locus for the human peptide antibiotic FALL-39.
Proc. Natl. Acad. Sci. USA
92:7085-7089[Abstract/Free Full Text].
|
| 7.
|
Harwig, S. S.,
V. N. Kokryakov,
K. M. Swiderek,
G. M. Aleshina,
C. Zhao, and R. I. Lehrer.
1995.
Prophenin-1, an exceptionally proline-rich antimicrobial peptide from porcine leukocytes.
FEBS Lett.
27:362:65-69.
|
| 8.
|
Harwig, S. S.,
A. Waring,
H. J. Yang,
Y. Cho,
L. Tan, and R. I. Lehrer.
1996.
Intramolecular disulfide bonds enhance the antimicrobial and lytic activities of protegrins at physiological sodium chloride concentrations.
Eur. J. Biochem.
240:352-357[Medline].
|
| 9.
|
Hultmark, D.,
A. Engstrom,
K. Andersson,
H. Steiner,
H. Bennich, and H. G. Boman.
1983.
Insect immunity: attacins, a family of antibacterial proteins from Hyalophora cecropia.
EMBO J.
2:571-576[Medline].
|
| 10.
|
Hultmark, D.,
A. Engstrom,
H. Bennich,
R. Kapur, and H. G. Boman.
1982.
Insect immunity: isolation and structure of cecropin D and four minor antibacterial components from Cecropia pupae.
Eur. J. Biochem.
127:207-217[Medline].
|
| 11.
|
Iwanaga, S.,
T. Muta,
T. Shigenaga,
N. Seki,
K. Kawano,
T. Katsu, and S. Kawabata.
1994.
Structure-function relationships of tachyplesins and their analogues.
Ciba Found. Symp.
186:160-174[Medline].
|
| 12.
|
Kokryakov, V. N.,
S. S. Harwig,
E. A. Panyutich,
A. A. Shevchenko,
G. M. Aleshina,
O. V. Shamova,
H. A. Korneva, and R. I. Lehrer.
1993.
Protegrins: leukocyte antimicrobial peptides that combine features of corticostatic defensins and tachyplesins.
FEBS Lett.
327:231-236[Medline].
|
| 13.
|
Lehrer, R. I., and M. J. Cline.
1969.
Interaction of Candida albicans with human leukocytes and serum.
J. Bacteriol.
98:996-1004[Abstract/Free Full Text].
|
| 14.
|
Lehrer, R. I.,
T. Ganz,
D. Szklarek, and M. E. Selsted.
1988.
Modulation of the in vitro candidacidal activity of human neutrophil defensins by target-cell metabolism and divalent cations.
J. Clin. Invest.
81:1829-1835.
|
| 15.
|
Lehrer, R. I.,
M. Rosenman,
S. S. L. Harwig,
R. Jackson, and P. Eisenhauer.
1991.
Ultrasensitive assays for endogenous antimicrobial polypeptides.
J. Immunol. Methods
137:167-173[Medline].
|
| 16.
|
Mangoni, M. E.,
A. Aumelas,
P. Charnet,
C. Roumestand,
L. Chiche,
E. Despaux,
G. Grassy,
B. Calas, and A. Chavanieu.
1996.
Change in membrane permeability induced by protegrin 1: implication of disulphide bridges for pore formation.
FEBS Lett.
383:93-98[Medline].
|
| 17.
|
Martin, E.,
T. Ganz, and R. I. Lehrer.
1995.
Defensins and other endogenous peptide antibiotics of vertebrates.
J. Leukocyte Biol.
58:128-136[Abstract].
|
| 17a.
|
National Committee for Clinical Laboratory Standards.
1992.
In
Document M-27-P.
National Committee for Clinical Laboratory Standards, Villanova, Pa.
|
| 18.
|
Pace, C. N.,
F. Vajdos,
L. Fee,
G. Grimsley, and T. Gray.
1995.
How to measure and predict the molar absorption coefficient of a protein.
Protein Sci.
4:2411-2423[Medline].
|
| 19.
|
Panyutich, A.,
J. Shi,
P. L. Boutz,
C. Zhao, and T. Ganz.
1997.
Porcine polymorphonuclear leukocytes generate extracellular microbicidal activity by elastase-mediated activation of secreted proprotegrins.
Infect. Immun.
65:978-985[Abstract].
|
| 20.
|
Qu, X. D.,
S. S. Harwig,
W. M. Shafer, and R. I. Lehrer.
1997.
Protegrin structure and activity against Neisseria gonorrhoeae.
Infect. Immun.
65:636-639[Abstract].
|
| 21.
|
Romeo, D.,
B. Skerlavaj,
M. Bolognesi, and R. Gennaro.
1988.
Structure and bactericidal activity of an antibiotic dodecapeptide purified from bovine neutrophils.
J. Biol. Chem.
263:9573-9575[Abstract/Free Full Text].
|
| 22.
|
Selsted, M. E.,
D. Szklarek, and R. I. Lehrer.
1984.
Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes.
Infect. Immun.
45:150-154[Abstract/Free Full Text].
|
| 23.
|
Simmaco, M.,
G. Mignogna,
D. Barra, and F. Bossa.
1994.
Antimicrobial peptides from skin secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin and brevinins and isolation of new active peptides.
J. Biol. Chem.
269:11956-11961[Abstract/Free Full Text].
|
| 24.
|
Steinberg, D. A.,
M. A. Hurst,
C. A. Fujii,
A. H. C. Kung,
J. F. Ho,
F. C. Cheng,
D. J. Loury, and J. F. Fiddes.
1997.
Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity.
Antimicrob. Agents. Chemother.
41:1738-1742[Abstract].
|
| 25.
|
Steinberg, D., and R. I. Lehrer.
1997.
Designer assays for antimicrobial peptides, p. 169-188.
In
W. M. Shafer (ed.), Methods in molecular biology. Humana Press, Totowa, N.J.
|
| 26.
|
Storici, P.,
G. Del Sal,
C. Schneider, and M. Zanetti.
1992.
cDNA sequence analysis of an antibiotic dodecapeptide from neutrophils.
FEBS Lett.
314:187-190[Medline].
|
| 27.
|
Storici, P.,
M. Scocchi,
I. A. Toss,
R. Gennaro, and M. Zanetti.
1994.
Chemical synthesis and biological activity of a novel antibacterial peptide deduced from a pig myeloid cDNA.
FEBS Lett.
337:303-307[Medline].
|
| 28.
|
Strukelj, B.,
J. Pungercar,
G. Kopitar,
M. Renko,
B. Lenarcic,
S. Berbic, and V. Turk.
1995.
Molecular cloning and identification of a novel porcine cathelin-like antibacterial peptide precursor.
Biol. Chem. Hoppe-Seyler
376:507-510[Medline].
|
| 29.
|
Suzuki, S.,
Y. Ohe,
T. Okubo,
T. Kakegawa, and K. Tatemoto.
1995.
Isolation and characterization of novel antimicrobial peptides, rugosins A, B, and C, from the skin of the frog, Rana rugosa.
Biochem. Biophys. Res. Commun.
212:249-254[Medline].
|
| 30.
|
Tam, J. P.,
C. R. Wu,
W. Liu, and J. W. Zang.
1991.
Disulfide bond formation in peptides by dimethyl sulfoxide. Scope and application.
J. Am. Chem. Soc.
113:6657-6662.
|
| 31.
|
Tamamura, H.,
T. Murakami,
S. Horiuchi,
K. Sugihara,
A. Otaka,
W. Takada,
T. Ibuka,
M. Waki,
N. Yamamoto, and N. Fujii.
1995.
Synthesis of protegrin-related peptides and their antibacterial and anti-human immunodeficiency virus activity.
Chem. Pharm. Bull.
43:853-858.
|
| 32.
|
Tossi, A.,
M. Scocchi,
M. Zanetti,
P. Storici, and R. Gennaro.
1995.
PMAP-37, a novel antibacterial peptide from pig myeloid cells. cDNA cloning, chemical synthesis and activity.
Eur. J. Biochem.
228:941-946[Medline].
|
| 33.
|
Yasin, B.,
R. I. Lehrer,
S. S. Harwig, and E. A. Wagar.
1996.
Protegrins: structural requirements for inactivating elementary bodies of Chlamydia trachomatis.
Infect. Immun.
64:4863-4866[Abstract].
|
| 34.
|
Zanetti, M.,
R. Gennaro, and D. Romeo.
1995.
Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain.
FEBS Lett.
374:1-5[Medline].
|
| 35.
|
Zanetti, M.,
P. Storici,
A. Tossi,
M. Scocchi, and R. Gennaro.
1994.
Molecular cloning and chemical synthesis of a novel antibacterial peptide derived from pig myeloid cells.
J. Biol. Chem.
269:7855-7858[Abstract/Free Full Text].
|
| 36.
|
Zhao, C.,
L. Liu, and R. I. Lehrer.
1994.
Identification of a new member of the protegrin family by cDNA cloning.
FEBS Lett.
346:285-288[Medline].
|
| 37.
|
Zhao, C.,
T. Ganz, and R. I. Lehrer.
1995.
Structures of genes for two cathelin-associated antimicrobial peptides prophenin-2 and PR-39.
FEBS Lett.
376:130-134[Medline].
|
| 38.
|
Zhao, C.,
T. Ganz, and R. I. Lehrer.
1995.
The structure of porcine protegrin genes.
FEBS Lett.
368:197-202[Medline].
|
Infect Immun, June 1998, p. 2486-2493, Vol. 66, No. 6
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wei, G., de Leeuw, E., Pazgier, M., Yuan, W., Zou, G., Wang, J., Ericksen, B., Lu, W.-Y., Lehrer, R. I., Lu, W.
(2009). Through the Looking Glass, Mechanistic Insights from Enantiomeric Human Defensins. J. Biol. Chem.
284: 29180-29192
[Abstract]
[Full Text]
-
Ghiselli, R., Giacometti, A., Cirioni, O., Mocchegiani, F., Silvestri, C., Orlando, F., Kamysz, W., Licci, A., Nadolski, P., Della Vittoria, A., Lukasiak, J., Scalise, G., Saba, V.
(2007). Pretreatment With the Protegrin IB-367 Affects Gram-Positive Biofilm and Enhances the Therapeutic Efficacy of Linezolid in Animal Models of Central Venous Catheter Infection. JPEN J Parenter Enteral Nutr
31: 463-468
[Abstract]
[Full Text]
-
Benincasa, M., Scocchi, M., Pacor, S., Tossi, A., Nobili, D., Basaglia, G., Busetti, M., Gennaro, R.
(2006). Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts. J Antimicrob Chemother
58: 950-959
[Abstract]
[Full Text]
-
Jenssen, H., Hamill, P., Hancock, R. E. W.
(2006). Peptide Antimicrobial Agents. Clin. Microbiol. Rev.
19: 491-511
[Abstract]
[Full Text]
-
Deslouches, B., Islam, K., Craigo, J. K., Paranjape, S. M., Montelaro, R. C., Mietzner, T. A.
(2005). Activity of the De Novo Engineered Antimicrobial Peptide WLBU2 against Pseudomonas aeruginosa in Human Serum and Whole Blood: Implications for Systemic Applications. Antimicrob. Agents Chemother.
49: 3208-3216
[Abstract]
[Full Text]
-
Giacometti, A, Cirioni, O, Ghiselli, R, Mocchegiani, F, D'Amato, G, Del Prete, M S., Orlando, F, Kamysz, W, Lukasiak, J, Saba, V, Scalise, G
(2003). Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. Gut
52: 874-878
[Abstract]
[Full Text]
-
Gidalevitz, D., Ishitsuka, Y., Muresan, A. S., Konovalov, O., Waring, A. J., Lehrer, R. I., Lee, K. Y. C.
(2003). Interaction of antimicrobial peptide protegrin with biomembranes. Proc. Natl. Acad. Sci. USA
100: 6302-6307
[Abstract]
[Full Text]
-
Steinstraesser, L., Tack, B. F., Waring, A. J., Hong, T., Boo, L. M., Fan, M.-H., Remick, D. I., Su, G. L., Lehrer, R. I., Wang, S. C.
(2002). Activity of Novispirin G10 against Pseudomonas aeruginosa In Vitro and in Infected Burns. Antimicrob. Agents Chemother.
46: 1837-1844
[Abstract]
[Full Text]